Renata PLC (DSE: RENATA)

Market Cap	75.30B
Revenue (ttm)	36.47B
Net Income (ttm)	2.29B
Shares Out	114.70M
EPS (ttm)	20.00
PE Ratio	32.82
Forward PE	18.49
Dividend	9.20 (1.40%)
Ex-Dividend Date	Oct 22, 2024

Volume	15,883
Open	668.90
Previous Close	658.50
Day's Range	655.00 - 668.90
52-Week Range	608.30 - 1,217.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Renata

Renata PLC manufactures, markets, distributes, and exports human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 7,119
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: RENATA

Financial Performance

In 2023, Renata's revenue was 32.97 billion, an increase of 6.12% compared to the previous year's 31.07 billion. Earnings were 2.34 billion, a decrease of -54.23%.